You are here
TANOX, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
N/A
Amount: $100,000.00N/A
SBIRPhase I2000Department of Health and Human Services National Institutes of Health -
Broad Cross-Reactivity of HIV-1 Neutralizing Antibody
Amount: $75,000.00Passive immunization with broadly neutralizing antibodies is a promising approach for preventionand treatment of HIV-1 infection. We have generated an HIV-1 neutralizing human antibody which bindsto t ...
SBIRPhase I1994Department of Health and Human Services -
ENHANCEMENT OF MUCOSAL IMMUNITY
Amount: $50,000.00THE RATE OF HETEROSEXUAL TRANSMISSION OF HIV-1 THROUGH SEXUAL CONTACTS IS INCREASING IN MOST COUNTRIES. LIKE MANY OTHER PATHOGENIC MICROORGANISMS, HIV-1 VIRIONS ENTER THE BODY THROUGH MUCOSAL SURFACE ...
SBIRPhase I1992Department of Health and Human Services -
IMMUNOTOXIN THERAPY FOR AIDS
Amount: $485,449.00THE GEOMETRIC INCREASE IN THE NUMBER OF INDIVIDUALS INFECTED BY HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) HAS CREATED SERIOUS SOCIAL, ECONOMIC, AND LIFE-THREATENING ISSUES FOR THE HUMAN RACE. IT IS ...
SBIRPhase II1991Department of Health and Human Services -
ANTI-IDIOTYPIC VACCINES FOR AIDS
Amount: $500,000.00THE GEOMETRIC INCREASE IN THE NUMBER OF INDIVIDUALS INFECTED BY HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) HAS CREATED SERIOUS SOCIAL, ECONOMICAL AND LIFE-THREATENING ISSUES TO THE HUMAN RACE. IT IS ...
SBIRPhase II1990Department of Health and Human Services -
EXPRESSION OF AN ANTI-IDIOTYPIC FV FRAGMENT AS A VACCINE FOR AIDS
Amount: $49,884.00TANOX BIOSYSTEMS, INC., HAS GENERATED AN ANTI-IDIOTYPE (ID) MONOCLONAL ANTIBODY (MAB), AB19-4, TO THE HIV-1-NEUTRALIZING MAB, BAT123, WHICH RECOGNIZES AN IMMUNODOMINANT REGION OF GP120. RESEARCH HAS C ...
SBIRPhase I1990Department of Health and Human Services -
CHIMERIC CD4/IMMUNOGLOBULIN ANTIBODIES FOR AIDS
Amount: $44,192.00ONE OF THE MOST URGENT CHALLENGES FACING THE MEDICAL COMMUNITY IS THE DEVELOPMENT OF EFFECTIVE THERAPEUTIC AGENTSFOR VICTIMS OF THE WORLDWIDE AIDS EPIDEMIC. BECAUSE OF THEIR HIGH DEGREE OF SPECIFICITY ...
SBIRPhase I1989Department of Health and Human Services -
IMMUNOTOXIN THERAPY FOR AIDS
Amount: $46,770.00N/A
SBIRPhase I1989Department of Health and Human Services -
ANTI-IDIOTYPIC VACCINES FOR AIDS
Amount: $45,000.00N/A
SBIRPhase I1988Department of Health and Human Services